These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 28645527)

  • 1. Inhibition of 17beta-hydroxysteroid dehydrogenase type 7 modulates breast cancer protein profile and enhances apoptosis by down-regulating GRP78.
    Wang XQ; Aka JA; Li T; Xu D; Doillon CJ; Lin SX
    J Steroid Biochem Mol Biol; 2017 Sep; 172():188-197. PubMed ID: 28645527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 17beta-hydroxysteroid dehydrogenase type 5 is negatively correlated to apoptosis inhibitor GRP78 and tumor-secreted protein PGK1, and modulates breast cancer cell viability and proliferation.
    Xu D; Aka JA; Wang R; Lin SX
    J Steroid Biochem Mol Biol; 2017 Jul; 171():270-280. PubMed ID: 28457968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutual regulations and breast cancer cell control by steroidogenic enzymes: Dual sex-hormone receptor modulation upon 17β-HSD7 inhibition.
    Sang X; Han H; Li T; Lin SX
    J Steroid Biochem Mol Biol; 2019 Oct; 193():105411. PubMed ID: 31207361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Substrate inhibition of 17β-HSD1 in living cells and regulation of 17β-HSD7 by 17β-HSD1 knockdown.
    Han H; Thériault JF; Chen G; Lin SX
    J Steroid Biochem Mol Biol; 2017 Sep; 172():36-45. PubMed ID: 28554725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergistic control of sex hormones by 17β-HSD type 7: a novel target for estrogen-dependent breast cancer.
    Wang X; Gérard C; Thériault JF; Poirier D; Doillon CJ; Lin SX
    J Mol Cell Biol; 2015 Dec; 7(6):568-79. PubMed ID: 25966904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estradiol-independent modulation of breast cancer transcript profile by 17beta-hydroxysteroid dehydrogenase type 1.
    Aka JA; Calvo EL; Lin SX
    Mol Cell Endocrinol; 2017 Jan; 439():175-186. PubMed ID: 27544780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The aromatase inhibitor letrozole and inhibitors of insulin-like growth factor I receptor synergistically induce apoptosis in in vitro models of estrogen-dependent breast cancer.
    Lisztwan J; Pornon A; Chen B; Chen S; Evans DB
    Breast Cancer Res; 2008; 10(4):R56. PubMed ID: 18611244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reductive 17beta-hydroxysteroid dehydrogenases which synthesize estradiol and inactivate dihydrotestosterone constitute major and concerted players in ER+ breast cancer cells.
    Zhang CY; Wang WQ; Chen J; Lin SX
    J Steroid Biochem Mol Biol; 2015 Jun; 150():24-34. PubMed ID: 25257817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro interactions between mammary fibroblasts (Hs 578Bst) and cancer epithelial cells (MCF-7) modulate aromatase, steroid sulfatase and 17β-hydroxysteroid dehydrogenases.
    Wang X; Sang X; Diorio C; Lin SX; Doillon CJ
    Mol Cell Endocrinol; 2015 Sep; 412():339-48. PubMed ID: 26044867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-125b upregulation confers aromatase inhibitor resistance and is a novel marker of poor prognosis in breast cancer.
    Vilquin P; Donini CF; Villedieu M; Grisard E; Corbo L; Bachelot T; Vendrell JA; Cohen PA
    Breast Cancer Res; 2015 Jan; 17(1):13. PubMed ID: 25633049
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GP88 (PC-Cell Derived Growth Factor, progranulin) stimulates proliferation and confers letrozole resistance to aromatase overexpressing breast cancer cells.
    Abrhale T; Brodie A; Sabnis G; Macedo L; Tian C; Yue B; Serrero G
    BMC Cancer; 2011 Jun; 11():231. PubMed ID: 21658239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Establishment of an aromatase inhibitor letrozole-resistant breast cancer cell model].
    Chen HY; Liu ZH
    Zhonghua Zhong Liu Za Zhi; 2013 Jun; 35(6):423-8. PubMed ID: 24119901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and mechanism of action of Proellex, an antiprogestin in aromatase overexpressing and Letrozole resistant T47D breast cancer cells.
    Gupta A; Mehta R; Alimirah F; Peng X; Murillo G; Wiehle R; Mehta RG
    J Steroid Biochem Mol Biol; 2013 Jan; 133():30-42. PubMed ID: 22939887
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of SNP variants in the 17β-HSD2 and 17β-HSD7 genes and 17β-HSD7 copy number on gene transcript and estradiol levels in breast cancer tissue.
    Straume AH; Knappskog S; Lønning PE
    J Steroid Biochem Mol Biol; 2014 Sep; 143():192-8. PubMed ID: 24560990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estrogen and androgen-converting enzymes 17β-hydroxysteroid dehydrogenase and their involvement in cancer: with a special focus on 17β-hydroxysteroid dehydrogenase type 1, 2, and breast cancer.
    Hilborn E; Stål O; Jansson A
    Oncotarget; 2017 May; 8(18):30552-30562. PubMed ID: 28430630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of microRNA-128a in regulating TGFbeta signaling in letrozole-resistant breast cancer cells.
    Masri S; Liu Z; Phung S; Wang E; Yuan YC; Chen S
    Breast Cancer Res Treat; 2010 Nov; 124(1):89-99. PubMed ID: 20054641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 17beta-hydroxysteroid dehydrogenase type 1 modulates breast cancer protein profile and impacts cell migration.
    Aka JA; Zerradi M; Houle F; Huot J; Lin SX
    Breast Cancer Res; 2012 Jun; 14(3):R92. PubMed ID: 22691413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Letrozole as a potent inhibitor of cell proliferation and expression of metalloproteinases (MMP-2 and MMP-9) by human epithelial breast cancer cells.
    Mitropoulou TN; Tzanakakis GN; Kletsas D; Kalofonos HP; Karamanos NK
    Int J Cancer; 2003 Mar; 104(2):155-60. PubMed ID: 12569569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aromatase and breast cancer.
    Brodie A; Sabnis G; Jelovac D
    J Steroid Biochem Mol Biol; 2006 Dec; 102(1-5):97-102. PubMed ID: 17113978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Model systems: mechanisms involved in the loss of sensitivity to letrozole.
    Brodie A; Jelovac D; Sabnis G; Long B; Macedo L; Goloubeva O
    J Steroid Biochem Mol Biol; 2005 May; 95(1-5):41-8. PubMed ID: 15967659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.